In July 2025, the company revised its sales and profit outlook for the year, reflecting slower-than-expected uptake for Wegovy and Ozempic, due to intensifying competition from arch-rival Eli Lilly LLY and compounded semaglutide alternatives in its largest obesity market, the United States
They target hair follicles at the cellular level, supporting natural regeneration, improved blood flow, and reduced inflammation
Wang R, Zhang JY, Zhang M, Zhai MG, Di SY, Han QH, et al
BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats
Hemodynamics are steadier
Anxiety in Late Life: An Update on Pathomechanisms